The Advisory Board of the Department of Bioengineering consists of a select group of industrial leaders and academic representatives who are primarily alumni of the department, or members of its constituent groups. They have shown leadership and professional success in their career, and are fully dedicated to helping Clemson University develop and maintain highly competitive research and educational programs in bioengineering.
Members of the Advisory Board serve at the pleasure of the Chair of the Department of Bioengineering and are appointed for a three-year term. Following a three-year term, members can be reappointed annually at the discretion of the Chair. A maximum of 15 members will serve on the Board at any given time. Membership representation shall reflect the bioengineering profession.
Stephen D. Ainsworth, Ph.D.
VP Research, Trans1, Inc.
Jennifer B. Cartledge, M.S.
CEO of CPD, ALUMNA
Harry Thomas Hall I.V.
M.S. Worldwide President, Trauma Synthes/J&J
Perry Halushka, M.D., Ph.D.
Dean, College of Graduate Studies Medical University of South Carolina
Kim P. Kelly, M.S.
Director, Regulatory Affairs, Bioventus
Eugene M. Langan, III, M.D., F.A.C.S.
Chairman, Department of Surgery, Greenville Hospital System-University Medical Center
Marc Long, Ph.D.
Director of Research and Innovation, Stryker Orthopaedics
Venture Partner, Hatteras Ventures
CEO, Midway Pharmaceuticals
Executive Director, Biomedical Engineering Society